Department of Clinical Laboratory, Beijing Bo'ai Hospital, China Rehabilitation Research Center, Beijing, China; School of Rehabilitation, Capital Medical University, Beijing, China.
Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.
J Int Adv Otol. 2021 Nov;17(6):492-499. doi: 10.5152/iao.2021.21086.
The aim of this study is to compare the spectrum and frequency of GJB2, SLC26A4, GJB3, and MT-RNR1 mutations in 4 different areas of China.
A total of 509 patients from Linyi, Xinxiang, Yichang, and Baise were enrolled in this study. Twenty of the most common mutation sites were analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Patients from Yichang (in central China; 22.50%) and Linyi (in eastern China; 23.55%) carried a greater proportion of the 5 most common GJB2 mutations compared with patients from the other 2 areas surveyed, namely Xinxiang (in the North China Plain) and Baise (in south-central China). In comparison, patients from Yichang (10.00%) and Xinxiang (12.94%) had a higher prevalence of the 11 most common SLC26A4 mutations. Interestingly, only 1 patient (1.47%) from Baise was confirmed to carry the c.1229C>T mutation of SLC26A4. Among the 20 mutation sites analyzed across these 4 genes, c.235delC in GJB2 and c.919-2A>G in SLC26A4 were the most common mutations across all 4 geographical regions. The c.235delC mutation in GJB2 was significantly more prevalent in Yichang (18.13%) and Linyi (18.31%) than in the other 2 areas, whereas the c.919-2A>G allele of SLC26A4 was present at much higher frequencies in Yichang (8.44%) and Xinxiang (8.74%) compared with the other areas.
This study increases the available data on hearing loss-associated mutations and provides evidence of the need for risk assessment and genetic counseling of populations from these 4 areas of China.
本研究旨在比较中国四个不同地区 GJB2、SLC26A4、GJB3 和 MT-RNR1 基因突变的谱和频率。
本研究共纳入来自临沂、新乡、宜昌和百色的 509 例患者。采用基质辅助激光解吸电离飞行时间质谱分析了 20 个最常见的突变位点。
与其他两个调查地区(华北平原的新乡和中南部的百色)相比,来自宜昌(中部地区;22.50%)和临沂(华东地区;23.55%)的患者携带 5 个最常见的 GJB2 突变的比例更大。相比之下,宜昌(10.00%)和新乡(12.94%)的患者 SLC26A4 的 11 个最常见突变的患病率更高。有趣的是,百色仅有 1 例(1.47%)患者携带 SLC26A4 的 c.1229C>T 突变。在这 4 个基因的 20 个突变位点分析中,GJB2 的 c.235delC 和 SLC26A4 的 c.919-2A>G 是所有 4 个地理区域最常见的突变。GJB2 的 c.235delC 突变在宜昌(18.13%)和临沂(18.31%)中明显比其他两个地区更为普遍,而 SLC26A4 的 c.919-2A>G 等位基因在宜昌(8.44%)和新乡(8.74%)中的出现频率明显高于其他地区。
本研究增加了有关听力损失相关突变的可用数据,并为中国这四个地区的人群进行风险评估和遗传咨询提供了证据。